These treatments did not reduce pericyte or endothelial cell numbers or cancer cell proliferation as measured by Ki67 staining; they did, however, downregulate vascular ERK (p-ERK) and AKT (p-S6R) signaling (Supplemental Figure 5, C and D). Here, AKT1 is linked to cancer.